Ovintiv (NYSE:OVV) Research Coverage Started at Barclays

Research analysts at Barclays started coverage on shares of Ovintiv (NYSE:OVV – Get Free Report) in a research report issued to clients and investors on Wednesday, MarketBeat reports. The brokerage set an “overweight” rating and a $69.00 price target on the stock. Barclays‘s target price points to a potential upside of 25.77% from the company’s […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) PT at $91.55
Next post South Korea March 2024: Kia Sorento signs 6th win in past 7 months, Tesla Model Y triumphs